General - Press Releases

Date	Title	Company
06-Dec-2023	NanoVibronix Featured in Your Bladder Health Magazine	Businesswire
06-Dec-2023	Resumen: Un nuevo análisis post hoc de datos de fase 3 muestra que AJOVY® (fremanezumab) redujo los ataques de migraña en adultos con migraña y obesidad comórbida	Businesswire
06-Dec-2023	IMIDomics and Bristol Myers Squibb Expand Long-Standing Partnership to Advance Immune-Mediated Inflammatory Disease Treatment Research and Development	Businesswire
06-Dec-2023	Riverbed Survey: Ninety-Three Percent of Manufacturing Decision-Makers Believe They Need to Provide More Advanced Digital Experiences to Remain Competitive as Next Generation Employees Enter the Workforce	Businesswire
06-Dec-2023	inTEST Continues Executing on Five-Point Strategy to Expand Geographically - Establishes Southeast Asia Center of Excellence in Malaysia	Businesswire
06-Dec-2023	IGC Pharma Announces Collaboration to Integrate AI into Clinical Trials	Businesswire
06-Dec-2023	TUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer	Businesswire
06-Dec-2023	Alentis Therapeutics Expands Leadership Team with the Appointment of Rizwan Velji as Chief Business Officer	Businesswire
06-Dec-2023	Delix Presents Interim Data From Phase I Trial of Novel Neuroplastogen at ACNP Annual Meeting	Businesswire
06-Dec-2023	Empress Therapeutics Appoints Virginia Finnerty-Brooks Chief Business Officer	Businesswire
06-Dec-2023	Ionpath Announces Executive Chair Appointment and CEO Promotion	Businesswire
06-Dec-2023	Asia-Pacific Nucleic Acid Therapeutics CDMO Market Report 2023-2033: Continued R&D for Manufacturing Innovative Nucleic Acid Therapeutics Forcing Pharmaceutical Companies to Expand their Businesses - ResearchAndMarkets.com	Businesswire
06-Dec-2023	COP28 Announcement Pushes for More Timber in Construction and More Sustainable Forestry	Businesswire
06-Dec-2023	Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Deuterated Psilocybin Analog Program	Businesswire
06-Dec-2023	Managing Service Providers including CRO (Contract Research Organisation) and CMOs Oversight to comply with ICH GCP (Good Clinical Practice) R3 Training Course - ResearchAndMarkets.com	Businesswire
06-Dec-2023	Global Peptide Therapeutics Markets, Drug Dosage, Price & Clinical Trials Insights, 2029 - ResearchAndMarkets.com	Businesswire
06-Dec-2023	Coya Therapeutics Announces $26.5 Million Private Placement	Businesswire
06-Dec-2023	Coya Therapeutics, Inc. and Dr. Reddy’s Laboratories Enter into an Exclusive Collaboration for Development and Commercialization of COYA 302, an Investigational Combination Therapy for Treatment of Amyotrophic Lateral Sclerosis (ALS)	Businesswire
06-Dec-2023	Abcuro Appoints Mark Pruzanski, M.D., as Chairman of its Board of Directors	Businesswire
06-Dec-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire